-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Shanghai Shangyao Ruier Pharmaceutical Co., Ltd., a subsidiary of the company, received the approval and issuance of the “Pharmaceutical Clinical Trial Approval Notice” for triprostenil diethanolamine inhalation powder from the State Drug Administration.

Zhitongcaijing·11/04/2026 08:57:07
Listen to the news
Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Shanghai Shangyao Ruier Pharmaceutical Co., Ltd., a subsidiary of the company, received the approval and issuance of the “Pharmaceutical Clinical Trial Approval Notice” for triprostenil diethanolamine inhalation powder from the State Drug Administration.